Search results
Results from the WOW.Com Content Network
All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out ...
Anne Wojcicki, CEO of 23andMe, has operated in "founder mode" for 18 years, say past executives. (Kyle Grillot—Bloomberg/Getty Images) Anne Wojcicki wanted to run things—alone.
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health Sasha Rogelberg November 12, 2024 at 1:14 PM
23andMe's board resigned over a "distracting difference of view" with cofounder Anne Wojcicki. The board rejected an earlier proposal by Wojcicki to take the company private.
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
(Reuters) - Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on ...